Related content

Three-year follow-up of pegylated interferon alfa-2b as monotherapy or in combination with lamivudine in patients with HBeAg-negative chronic hepatitis B

By Papadopoulos Vasileios   Protopapas Andreas   Tsianos Epameinondas   Mimidis Konstantinos  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 8, 2009-08 ,pp. : 1021-1022

Informa Healthcare

Access to resources Recommend Favorite

Non-invasive assessment of changes in liver fibrosis via liver stiffness measurement in patients with chronic hepatitis B: impact of antiviral treatment on fibrosis regression

By Kim Seung  

Hepatology International, Vol. 4, Iss. 4, 2010-12 ,pp. : 673-680

Springer Publishing Company

Access to resources Recommend Favorite

Cost-effectiveness of Interferon Alfa-2b With and Without Ribavirin as Therapy for Chronic Hepatitis C in Sweden

By Sennfält K.   Reichard O.   Hultkrantz R.   Wong J. B.   Jonsson D.  

Scandinavian Journal of Gastroenterology, Vol. 36, Iss. 8, 2001-08 ,pp. : 870-876

Informa Healthcare

Access to resources Recommend Favorite

Comparison of non-invasive assessment to diagnose liver fibrosis in chronic hepatitis B and C patients

By Stibbe Krista J. M.   Verveer Claudia   Francke Jan   Hansen Bettina E.   Zondervan Pieter E.   Kuipers Ernst J.   de Knegt Robert J.   van Vuuren Anneke J.  

Scandinavian Journal of Gastroenterology, Vol. 46, Iss. 7-8, 2011-07 ,pp. : 962-972

Informa Healthcare

Access to resources Recommend Favorite

Non-Invasive Index for Predicting Significant Liver Fibrosis: Comparison of Diagnostic Performances in Patients with Chronic Hepatitis B and C

By Cheong Jae   Um Soon   Seo Yeon   Kim Dong   Hwang Seong   Lee Youn   Cho Mong   Yang Jin   Kim Young   Park Young   Cho Sung  

Digestive Diseases and Sciences, Vol. 56, Iss. 2, 2011-02 ,pp. : 555-563

Springer Publishing Company

Access to resources Recommend Favorite